Publication Name	World Journal of Gastroenterology
Manuscript ID	14476
Country	Japan

Received	2014-10-06 12:50
Peer-Review Started	2014-10-06 18:25
First Decision by Editorial Office Director
Return for Revision	2014-11-03 10:18
Revised	2014-11-12 14:32
Publication Fee Transferred
Second Decision by Editor	2014-12-16 15:25
Second Decision by Editor-in-Chief	2014-12-18 10:20
Final Decision by Editorial Office Director	2014-12-22 17:01
Articles in Press	2014-12-22 17:22
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-10 17:23
Publish the Manuscript Online	2015-03-30 14:23

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: A potential beneficial effect on psoriasis vulgaris
Manuscript Source	Unsolicited Manuscript
All Author List	Ken Okamoto, Hiromichi Maeda, Takeo Shiga, Mai Shiga, Ken Dabanaka, Kazuhiro Hanazaki and Michiya Kobayashi
Funding Agency and Grant Number
Corresponding Author	Dr. Ken Okamoto, Department of Human Health and Medical Sciences, Kochi Medical School Hospital, Kohasu, Oko-cho, Nankoku-city, Kochi 783-8505, Japan. okamoto@kochi-u.ac.jp
Key Words	Psoriasis; Cetuximab; Panitumumab; Epidermal growth factor receptor; Colorectal cancer
Core Tip	Anti- epidermal growth factor receptor (EGFR) antibodies are effective in treating advanced colorectal cancer. However, anti-EGFR antibodies are not generally used in patients with concomitant chronic skin disease due to dermatological toxicities. In this case report, we present a patient with psoriasis vulgaris whose symptoms lessened during treatment with anti-EGFR antibody monotherapy for metastatic colon cancer. Based on this result, we consider that patients with concomitant skin disease should still be considered for anti-EGFR antibody therapy.
Publish Date	2015-03-30 14:23
Citation	Okamoto K, Maeda H, Shiga T, Shiga M, Dabanaka K, Hanazaki K, Kobayashi M. Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: A potential beneficial effect on psoriasis vulgaris. World J Gastroenterol 2015; 21(12): 3746-3749
URL	http://www.wjgnet.com/1007-9327/full/v21/i12/3746.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i12.3746

Full Article (PDF)	WJG-21-3746.pdf
Full Article (Word)	WJG-21-3746.doc
Manuscript File	14476-Review.docx
Answering Reviewers	14476-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14476-Conflict-of-interest statement.pdf
Copyright License Agreement	14476-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	14476-Institutional Review Board (IRB) statement.pdf
Non-Native Speakers of English Editing Certificate	14476-Language certificate.pdf
Peer-review Report	14476-Peer review(s).pdf
Scientific Misconduct Check	14476-CorssCheck.jpg
Scientific Editor Work List	14476-Scientific editor work list.pdf